Ligne de temps
Marie-Louise Michel
Chercheur(euse) Retraité(e)
01 août 2023
publication
Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks.
Lire plus01 juin 2023
publication
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells
Lire plus11 mars 2023
publication
Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys
Lire plus01 févr. 2023
publication
Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.
Lire plus01 déc. 2022
publication
Les virus au service de la santé : la vaccination Viruses to rescue health: Vaccination
Lire plus01 oct. 2022
publication
Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25
Lire plus15 juil. 2022
publication
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
Lire plus24 mai 2022
publication
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Lire plus15 avr. 2022
publication
Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus.
Lire plus22 déc. 2021
publication
sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs
Lire plus01 nov. 2021
publication
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
Lire plus27 sept. 2021
publication
HIV-1 hijacks the cell extracellular matrix to spread collectively and efficiently between T lymphocytes
Lire plus09 sept. 2021
01 sept. 2021
publication
Discovery of genes that modulate flavivirus replication in an interferon-dependent manner
Lire plus27 janv. 2021
publication
Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65–iASPP Protein Complex
Lire plus27 oct. 2020
publication
Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus
Lire plus01 mai 2020
publication
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus
Lire plus01 janv. 2020
01 janv. 2019
publication
Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections
Lire plus06 août 2015
publication
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial
Lire plus23 juil. 2015
publication
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes
Lire plus02 juil. 2015
publication
HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase
Lire plus10 févr. 2015
publication
Towards an HBV cure: state-of-the-art and unresolved questions–report of the ANRS workshop on HBV cure
Lire plus01 janv. 2015
16 déc. 2014
publication
Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?
Lire plus26 nov. 2014
publication
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Lire plus27 juin 2014
publication
Human hematopoietic reconstitution and HLA-restricted responses in nonpermissive alymphoid mice
Lire plus20 mars 2014
publication
Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli.
Lire plus19 mars 2014
publication
Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection
Lire plus03 févr. 2014
publication
In Vitro Activities of Dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa Planktonic Growth and Biofilm Formation
Lire plus29 janv. 2014
publication
Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro
Lire plus26 déc. 2013
publication
Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection
Lire plus06 mars 2013
publication
Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules
Lire plus15 mai 2012
publication
Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model
Lire plus20 juil. 2011
publication
Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice
Lire plus14 janv. 2011
publication
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges
Lire plus31 mars 2010
publication
Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo
Lire plus18 janv. 2010
publication
Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination
Lire plus08 déc. 2009
publication
ViralORFeome: an integrated database to generate a versatile collection of viral ORFs.
Lire plus01 nov. 2009
publication
Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models
Lire plus01 oct. 2009
publication
Sequence analysis of the large (L) polymerase gene and trailer of the peste des petits ruminants virus vaccine strain Nigeria 75/1: expression and use of the L protein in reverse genetics.
Lire plus14 mars 2007
publication
Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients
Lire plus12 sept. 2006
publication
Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects
Lire plus01 déc. 2005
18 août 2005
publication
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers
Lire plus20 mai 2005
publication
Loss of reactivity of vaccine-induced CD4 T cells in immunized monkeys after SIV/HIV challenge
Lire plus01 mai 2005
16 mars 2005
publication
In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus
Lire plus01 janv. 2005
publication
In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice
Lire plus15 déc. 2004
publication
A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.
Lire plus01 nov. 2004
publication
A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice
Lire plus01 oct. 2004
publication
Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers
Lire plus01 sept. 2004
publication
Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles
Lire plus12 juil. 2004
publication
Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules
Lire plus01 oct. 2003